Discount Code (0% Off) has been applied.
 
Enter a search term.

If you can't find what you were looking for, please contact us using one of the methods below so we can better serve you.

1 (800) 854-7220
answers@mcguff.com Suggest an Item
Manufacturer: Hospira

..

001029
001029
Manufacturer: Hospira (Shop the Brand)

Bacteriostatic 0.9% Sodium Chloride Injection 9 mg/mL, Multiple Dose Vial 30 mL, Each

Item Code: 001028
Mfg Part #: 00409-1966-02
$6.50
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Sodium Chloride
Route of Administration Intravenous (IV) Infusion, Intramuscular (IM), Subcutaneous (SC), Intraocular
Strength 0.9%
Volume 30 mL
Feature Sterile, Nonpyrogenic
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Electrolyte

Bacteriostatic 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution containing sodium chloride 9 mg/mL with benzyl alcohol 9 mg/mL as a bacteriostatic preservative. Distributed by Hospira, Inc., this prescription-only parenteral preparation is indicated exclusively as a diluent or solvent for dissolving or diluting drugs prior to intravenous, intramuscular, or subcutaneous injection.

Available in multiple-dose vials (10 mL, 20 mL, and 30 mL), this preparation is supplied in a semi-rigid polyolefin container and is designed for repeated withdrawals in clinical settings. Not for use in neonates. Not for inhalation. For drug diluent use only.

Key Benefits

  • Bacteriostatic Preservation: Contains 0.9% benzyl alcohol to inhibit microbial growth across multiple-dose withdrawals, maintaining sterility throughout use.
  • Isotonic Formulation: Physiologically matched to body fluids, minimizing the risk of osmotic disruption when used as a drug vehicle.
  • Multiple-Dose Convenience: Semi-rigid polyolefin vials support repeated aseptic withdrawals, reducing preparation steps in high-volume clinical environments.
  • Broad Parenteral Compatibility: Suitable as a diluent for IV, IM, and subcutaneous drug administration per individual drug manufacturer guidance.
  • Sterile and Nonpyrogenic: Manufactured to USP standards; pH 5.0 (range 4.5–7.0) with optional hydrochloric acid for pH adjustment.

Dosage and Administration

The volume of this preparation used for diluting or dissolving any injectable drug is determined by the drug manufacturer's recommended vehicle concentration, dose, and route of administration. Consult individual drug labeling for specific dilution instructions.

  • Routes: Intravenous, intramuscular, or subcutaneous — per the drug to be administered.
  • Preparation: Use aseptic technique for all entries and withdrawals. Mix reconstituted solutions thoroughly and use promptly unless otherwise directed by the solute manufacturer.
  • Visual Inspection: Inspect all reconstituted solutions for particulate matter and discoloration prior to administration. Do not use unless the solution is clear and the seal is intact.

Why Choose Bacteriostatic 0.9% Sodium Chloride Injection?

  • Multi-Dose Efficiency: Supports repeated use from a single vial, reducing waste and preparation time in clinical workflows.
  • Trusted Hospira Platform: Distributed by Hospira, Inc. (Lake Forest, IL) under NDA018800; a well-established parenteral product in hospital and outpatient settings.
  • Flexible Volume Options: Available in 10 mL, 20 mL, and 30 mL vials (trays of 25) to accommodate varied dosing requirements.

Warnings

  • Contraindicated in Neonates: Benzyl alcohol has been associated with serious toxicity and fatality in neonates. Solutions containing benzyl alcohol must not be used in this population under any circumstances.
  • Not for Epidural or Spinal Use: Parenteral preparations containing benzyl alcohol are contraindicated for epidural or intrathecal administration.
  • Drug Incompatibility Risk: Some injectable drugs may be incompatible with benzyl alcohol-containing vehicles. Consult a pharmacist prior to use; do not store reconstituted solutions unless directed by the solute manufacturer.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Bacteriostatic 09 Sodium Chloride Injection 9 mgmL Multiple Dose Vial 30 mL 25Tray
Bacteriostatic 0.9% Sodium Chloride Injection 9 mg/mL, Multiple Dose Vial 30 mL
Bacteriostatic 0.9% Sodium Chloride Injection 9 mg/mL, Multiple Dose Vial 30 mL
Manufacturer: Hospira (Shop the Brand)

Bacteriostatic 0.9% Sodium Chloride Injection 9 mg/mL, Multiple Dose Vial 30 mL, 25/Tray

Item Code: 009522
Mfg Part #: 00409-1966-07
$146.25
Requires Verified Medical License to Purchase
To reduce overall packaging and shipping costs, our shipping department will pack your orders in as few boxes as possible. Compounded drugs must ship separately from our other products. When choosing Next Day or 2nd Day Air shipping methods, final shipping totals will be calculated when your order is packed and invoiced. Box size and package destination does not affect shipping fee calculations. The number of boxes is determined by size, weight and quantity of products ordered. For additional information or questions, please contact us.
About This Product

..

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Sodium Chloride
Route of Administration Intravenous (IV) Infusion, Intramuscular (IM), Subcutaneous (SC), Intraocular
Strength 0.9%
Volume 30 mL
Feature Sterile, Nonpyrogenic
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Electrolyte

Bacteriostatic 0.9% Sodium Chloride Injection, USP is a sterile, nonpyrogenic, isotonic solution containing sodium chloride 9 mg/mL with benzyl alcohol 9 mg/mL as a bacteriostatic preservative. Distributed by Hospira, Inc., this prescription-only parenteral preparation is indicated exclusively as a diluent or solvent for dissolving or diluting drugs prior to intravenous, intramuscular, or subcutaneous injection.

Available in multiple-dose vials (10 mL, 20 mL, and 30 mL), this preparation is supplied in a semi-rigid polyolefin container and is designed for repeated withdrawals in clinical settings. Not for use in neonates. Not for inhalation. For drug diluent use only.

Key Benefits

  • Bacteriostatic Preservation: Contains 0.9% benzyl alcohol to inhibit microbial growth across multiple-dose withdrawals, maintaining sterility throughout use.
  • Isotonic Formulation: Physiologically matched to body fluids, minimizing the risk of osmotic disruption when used as a drug vehicle.
  • Multiple-Dose Convenience: Semi-rigid polyolefin vials support repeated aseptic withdrawals, reducing preparation steps in high-volume clinical environments.
  • Broad Parenteral Compatibility: Suitable as a diluent for IV, IM, and subcutaneous drug administration per individual drug manufacturer guidance.
  • Sterile and Nonpyrogenic: Manufactured to USP standards; pH 5.0 (range 4.5–7.0) with optional hydrochloric acid for pH adjustment.

Dosage and Administration

The volume of this preparation used for diluting or dissolving any injectable drug is determined by the drug manufacturer's recommended vehicle concentration, dose, and route of administration. Consult individual drug labeling for specific dilution instructions.

  • Routes: Intravenous, intramuscular, or subcutaneous — per the drug to be administered.
  • Preparation: Use aseptic technique for all entries and withdrawals. Mix reconstituted solutions thoroughly and use promptly unless otherwise directed by the solute manufacturer.
  • Visual Inspection: Inspect all reconstituted solutions for particulate matter and discoloration prior to administration. Do not use unless the solution is clear and the seal is intact.

Why Choose Bacteriostatic 0.9% Sodium Chloride Injection?

  • Multi-Dose Efficiency: Supports repeated use from a single vial, reducing waste and preparation time in clinical workflows.
  • Trusted Hospira Platform: Distributed by Hospira, Inc. (Lake Forest, IL) under NDA018800; a well-established parenteral product in hospital and outpatient settings.
  • Flexible Volume Options: Available in 10 mL, 20 mL, and 30 mL vials (trays of 25) to accommodate varied dosing requirements.

Warnings

  • Contraindicated in Neonates: Benzyl alcohol has been associated with serious toxicity and fatality in neonates. Solutions containing benzyl alcohol must not be used in this population under any circumstances.
  • Not for Epidural or Spinal Use: Parenteral preparations containing benzyl alcohol are contraindicated for epidural or intrathecal administration.
  • Drug Incompatibility Risk: Some injectable drugs may be incompatible with benzyl alcohol-containing vehicles. Consult a pharmacist prior to use; do not store reconstituted solutions unless directed by the solute manufacturer.

Disclaimer: This product description was generated by AI and is intended for informational purposes only. Please consult the latest package insert.
Products specifications
Brands in this category
Picture for manufacturer American Regent
Picture for manufacturer Exela
Picture for manufacturer Hospira
Picture for manufacturer McGuff Pharmaceuticals
Picture for manufacturer Mylan

Featured Articles

McGuff’s Promise of Quality and Service

For over 50 years, we’ve been the trusted name in healthcare excellence. Medical practitioners can rely on us for quality products, fast deliveries, and superior service. We strive for customer satisfaction and maintaining that trust.

We at the McGuff Company, Inc. (McGuff) work very hard to provide you accurate and timely information on our website. However, it is your obligation to verify such information before using the products purchased from McGuff.

All information is provided “As-is” and may change without prior notice. McGuff does not make warranty or representation that the information contained on this site is accurate, current, or complete.

Any use of information by you is without recourse to McGuff and is at your own risk.

McGuff is in no way responsible for any damages whether direct, consequential, incidental, or otherwise suffered by you or others on your behalf as a result of using or relying upon such information for any purpose.

Products specifications
Medical License Required Yes
Class Rx Only
Product Name Injection
Generic Name Sodium Chloride
Route of Administration Intravenous (IV) Infusion, Intramuscular (IM), Subcutaneous (SC), Intraocular
Strength 0.9%
Volume 30 mL
Feature Sterile, Nonpyrogenic
Storage Requirements USP Controlled Room Temperature
Storage Temperature 20º to 25ºC (68 to 77ºF)
Therapeutic Class Electrolyte

Contact Us

McGuff Company is LegitScript Certified

Copyright © 2026 McGuff Company, Inc. All rights reserved.

For information on the duties and responsibilities of this web site, please read our privacy policy and our warning and disclaimer . Use of this website signifies your agreement to the Privacy Policy and Warning Disclaimer.

Coronavirus (COVID-19)

Due to the Coronavirus (COVID-19) outbreak worldwide, the global demand for some Personal Protective Equipment (PPE) is exceeding current supply availability.

In addition, the manufacturing of the PPE and many other wound care/infection prevention products have been impacted by the global response to the Coronavirus. While you may see product availability reduction in the near-term, please be assured that we at McGuff Medical are continuing to work diligently to ensure an uninterrupted supply of products and alternative products to you.

Additionally, in order to ensure healthcare providers have access to the PPEs they need, the McGuff Company is temporarily limiting PPEs to healthcare providers.

As always, please feel free to reach out to our McGuff Customer Service team with any questions that you may have.

Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President